Study of high-dose Zocor deals blow to Merck
115250
A high-dose regimen of Merck&#39;s cholesterol drug Zocor offered no conclusive benefits over a low-cholesterol diet and a lower dose of Zocor in preventing a recurrence of cardiac events
200299
The recall of Vioxx--an arthritis treatment taken by millions of people--is a disaster for everyone. Of course it&#39;s bad news for Merck (nyse: MRK - news - people), the drug&#39;s maker.
217345
Merck&#39;s (MRK:NYSE - news - research) withdrawn painkiller, Vioxx, could soon leave pharmacy benefit manager (PBM) Medco (MHS:NYSE - news - research) with its own headaches.
22206
Internal e-mails and other documents from Merck &amp; Co. show the company fought for years to keep safety concerns from undermining the drug&#39;s commercial prospects, the Wall Street Journal reported on Monday.
313849
Merck &amp; Co., under siege because of lost revenues from its recalled blockbuster arthritis drug Vioxx, will cut about 5,100 jobs by year&#39;s end, more than originally planned, and will slash hundreds of millions of dollars in spending, Chairman Raymond V
380901
Merck said it voluntarily pulled the drug after new data from a clinical trial found an increased risk of heart attack and stroke.
315924
Merck &amp; Co.&#39;s Vioxx painkiller showed heart risk in studies four years before the drug was recalled, and it should have been pulled from the market then, according to a study published in the medical journal Lancet.
174438
In a disappointing setback, a promising experimental AIDS vaccine failed to work in a large international test, leading the developer to halt the study. Merck &amp; Co. said Friday that it is ending enrollment and vaccination of volunteers in the study, which was partly funded by the National Institutes of Health.
398157
An experimental cholesterol treatment touted by drugmaker Merck &amp; Co. significantly reduced artery-clogging fats in late-stage testing, but it got a mixed reception from Wall Street analysts Tuesday.
424010
Merck said that it would stop selling Vioxx because a study found that it doubled patients' risk of heart attack and strokes.
628834
Merck & Co Inc. on Thursday pulled its  arthritis drug Vioxx off the market after a study showed it  doubled the risk of heart attack and stroke, a move that sent  its shares plunging and erased $25 billion from its market  value.
64799
Merck&#39;s (nyse: MRK - news - people ) decision is based on new three-year data from a clinical trial designed to test the effect of Vioxx on preventing colorectalpolyps.
361813
The Wall Street Journal has reported that pharmaceutical company Merck knew as far back as 2000 that its arthritis medication, Vioxx, was linked to an increased risk of heart attack.
275318
Shares of Merck &amp; Co. (MRK.N: Quote, Profile, Research) fell on Thursday after a US study suggested that patients taking its Vioxx arthritis drug had a 50 percent greater risk
125028
Drug company Merck has removed its painkiller Vioxx because of data showing an increased risk of heart attack and stroke.
253668
Shares of Merck (MRK) plunged more than 7% Monday after a report said the pharmaceutical giant apparently hid or denied evidence for years that its blockbuster arthritis drug Vioxx causes heart problems.
320680
Pharmaceutical titan Merck &amp; Co. Inc. yesterday pulled its blockbuster arthritis drug Vioxx off the market, citing safety concerns, thereby triggering a massive selloff in the company&#39;s shares that wiped out nearly US$27-billion of Merck&#39;s market value.